🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "focused steps to address cost of living challenges" in the upcoming Budget.

In comments to the BBC, she emphasized that reducing price rises is a shared task of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the most elevated among the G7 developed nations this calendar year and next.

Potential Energy Cost Interventions

Sources suggest the government could intervene to reduce utility costs, such as by reducing the present 5% level of VAT applied on energy supplies.

A further option is to reduce some of the policy costs presently included in bills.

Fiscal Limitations and Expert Predictions

The government will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much space there is for these actions.

The expectation from the majority of economists is that Reeves will have to declare tax rises or spending cuts in order to adhere to her voluntary fiscal targets.

Earlier on the same day, calculations suggested there was a £22bn deficit for the Treasury chief to fill, which is at the lower end of expectations.

"There's a joint job between the central bank and the administration to further reduce some of the causes of price increases," Reeves stated to reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and International Concerns

While a great deal of the focus has been on likely tax rises, the chancellor said the most recent information from the OBR had not changed her vow to election pledges not to increase tax levels on earnings tax, sales tax or social security contributions.

She attributed an "uncertain world" with growing geopolitical and trade tensions for the fiscal tax moves, likely to be focused on those "most able to pay."

International Trade Disputes

Commenting on worries about the UK's trade ties with the Asian nation she said: "Our national security always are paramount."

Last week's statement by China to strengthen trade restrictions on rare earths and other materials that are crucial for high-technology manufacturing led American leader the US President to propose an further 100% import tax on imports from the Asian country, increasing the possibility of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary labeled China's action "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the American proposal to join its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "harmful for the international commerce and creates further challenges."

"In my view there are areas where we should confront Chinese policies, but there are also significant opportunities to export to China's economy, including banking sector and other sectors of the economy. We've got to get that balance right."

The chancellor also affirmed she was cooperating with other major economies "on our own essential resources plan, so that we are reduced dependence."

NHS Drug Pricing and Funding

Reeves also admitted that the price the NHS spends on drugs could rise as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or abandoning operations in the United Kingdom, with several blaming the insufficient payments they are receiving.

Last month, the government science advisor said the cost the NHS pays for drugs would have to rise to stop companies and drug research funding departing from the UK.

The Chancellor informed the BBC: "It has been observed as a result of the payment system, that drug testing, innovative medicines have not been offered in the United Kingdom in the manner that they are in other continental states."

"The objective is to make sure that patients receiving care from the NHS are can obtain the finest life-saving medicines in the world. And so we are looking at all of that, and... seeking to obtain more funding into the UK."